MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjcard.2022.09.029

Медицинская библиотека · The American journal of cardiology · 2022

Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.

Basmadjian Lauren, Bouabdallaoui Nadia, Simard François, O'Meara Eileen, Ducharme Anique, Rouleau Jean-Lucien, Racine Normand, White Michel, Sirois Martin G, Asgar Anita, Ibrahim Reda, Dorval Jean-François, Bonan Raoul, Cartier Raymond, Forcillo Jessica, El-Hamamsy Ismail, Henri Christine

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

In aortic stenosis (AS), left ventricular (LV) remodeling often occurs before symptom onset, and early intervention may be beneficial. Risk stratification remains challenging and identification of biomarkers may be useful. We evaluated the association between growth differentiation factor-15 (GDF-15) and soluble suppression of tumorigenicity 2 (sST2) and known markers of poor prognosis in AS. Baseline plasma GDF-15 and sST2 levels were measured in 70 patients with moderate-severe AS (aortic valve area <1.5 cm2) and preserved LV ejection fraction (>45%). Patients were categorized into "low GDF-15" versus "high GDF-15" and "low sST2" versus "high sST2" groups. Groups were compared for differences in cardiovascular risk factors, 6-minute walk test, 5 m gait speed, cognitive function (Montreal Cognitive Assessment), and echocardiographic parameters. Overall, 44% of patients were deemed asymptomatic by New York Heart Association class, 61% had severe AS (aortic valve area <1 cm2) and all patients had preserved LV ejection fraction. GDF-15 levels were not predictive of AS severity. However, high GDF-15 (>1,050 pg/ml) was associated with LV dysfunction as shown by lower indexed stroke volume (p <0.01), worse LV global longitudinal strain (p = 0.04), greater mean E/e' (p = 0.02) and indexed left atrial volume (p <0.01). It was also associated with decreased functional capacity with shorter 6-minute walk test (p = 0.01) and slower 5 m gait speed (p = 0.02). Associations between sST2 levels and markers of poor prognosis were less compelling. In this study of patients with moderate to severe AS, elevated GDF-15 levels are associated with impaired functional capacity, poorer performance on fragility testing, and LV dysfunction. In conclusion, GDF-15 may integrate these markers of adverse outcomes into a single biomarker of poor prognosis.

Для цитирования: Basmadjian Lauren, Bouabdallaoui Nadia, Simard François, O'Meara Eileen, Ducharme Anique, Rouleau Jean-Lucien, Racine Normand, White Michel, Sirois Martin G, Asgar Anita, Ibrahim Reda, Dorval Jean-François, Bonan Raoul, Cartier Raymond, Forcillo Jessica, El-Hamamsy Ismail, Henri Christine. Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.. The American journal of cardiology. 2022. DOI: 10.1016/j.amjcard.2022.09.029.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.